WallStSmart

Advanced Energy Industries Inc (AEIS)vsWest Pharmaceutical Services Inc (WST)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

West Pharmaceutical Services Inc generates 69% more annual revenue ($3.22B vs $1.91B). WST leads profitability with a 16.9% profit margin vs 10.0%. AEIS appears more attractively valued with a PEG of 2.77. WST earns a higher WallStSmart Score of 65/100 (C+).

AEIS

Buy

59

out of 100

Grade: C

Growth: 6.7Profit: 6.0Value: 3.0Quality: 7.8
Piotroski: 6/9Altman Z: 2.97

WST

Buy

65

out of 100

Grade: C+

Growth: 7.3Profit: 8.0Value: 2.7Quality: 7.3
Piotroski: 5/9Altman Z: 4.91
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for AEIS.

WSTSignificantly Overvalued (-32.4%)

Margin of Safety

-32.4%

Fair Value

$185.95

Current Price

$322.30

$136.35 premium

UndervaluedFair: $185.95Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AEIS2 strengths · Avg: 9.0/10
EPS GrowthGrowth
144.8%10/10

Earnings expanding 144.8% YoY

Revenue GrowthGrowth
26.3%8/10

Revenue surging 26.3% year-over-year

WST4 strengths · Avg: 9.0/10
EPS GrowthGrowth
56.1%10/10

Earnings expanding 56.1% YoY

Altman Z-ScoreHealth
4.9110/10

Safe zone — low bankruptcy risk

Operating MarginProfitability
21.7%8/10

Strong operational efficiency at 21.7%

Revenue GrowthGrowth
21.0%8/10

Revenue surging 21.0% year-over-year

Areas to Watch

AEIS4 concerns · Avg: 2.5/10
Price/BookValuation
9.8x4/10

Trading at 9.8x book value

PEG RatioValuation
2.772/10

Expensive relative to growth rate

P/E RatioValuation
74.1x2/10

Premium valuation, high expectations priced in

Free Cash FlowQuality
$-42.60M2/10

Negative free cash flow — burning cash

WST2 concerns · Avg: 2.0/10
PEG RatioValuation
3.142/10

Expensive relative to growth rate

P/E RatioValuation
43.5x2/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : AEIS

The strongest argument for AEIS centers on EPS Growth, Revenue Growth. Revenue growth of 26.3% demonstrates continued momentum.

Bull Case : WST

The strongest argument for WST centers on EPS Growth, Altman Z-Score, Operating Margin. Profitability is solid with margins at 16.9% and operating margin at 21.7%. Revenue growth of 21.0% demonstrates continued momentum.

Bear Case : AEIS

The primary concerns for AEIS are Price/Book, PEG Ratio, P/E Ratio. A P/E of 74.1x leaves little room for execution misses.

Bear Case : WST

The primary concerns for WST are PEG Ratio, P/E Ratio. A P/E of 43.5x leaves little room for execution misses.

Key Dynamics to Monitor

AEIS carries more volatility with a beta of 1.40 — expect wider price swings.

AEIS is growing revenue faster at 26.3% — sustainability is the question.

WST generates stronger free cash flow (47M), providing more financial flexibility.

Monitor ELECTRICAL EQUIPMENT & PARTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

WST scores higher overall (65/100 vs 59/100), backed by strong 16.9% margins and 21.0% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Advanced Energy Industries Inc

INDUSTRIALS · ELECTRICAL EQUIPMENT & PARTS · USA

Advanced Energy Industries, Inc. designs, manufactures, sells and supports precision energy conversion, measurement and control solutions globally. The company is headquartered in Denver, Colorado.

West Pharmaceutical Services Inc

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

West Pharmaceutical Services, Inc. is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems. The company is headquartered in Exton, Pennsylvania.

Want to dig deeper into these stocks?